Chuo-ku, Japan

Miyako Kakuma

This inventor holds 1 USPTO granted patent. Top assignee: Nagase Co., Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miyako Kakuma. Retrieved from https://idiyas.com/inventor/miyako-kakuma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miyako Kakuma: Innovator in Hyperlipemia Treatment

Introduction

Miyako Kakuma is a notable inventor based in Chuo-ku, Japan. She has made significant contributions to the field of medical science, particularly in the treatment of hyperlipemia. Her innovative approach has the potential to impact the health of many individuals suffering from related diseases.

Latest Patents

Kakuma holds a patent for a method aimed at inhibiting hyperlipemia using emmeisou or an extract thereof. The patent, titled "Method for inhibiting hyperlipemia with emmeisou or an extract thereof," outlines a process that involves administering emmeisou or its extract to a subject. This method addresses hyperlipemia, which is linked to various diseases, including arteriosclerosis.

Career Highlights

Miyako Kakuma is associated with Nagase Co., Ltd., where she continues to develop her research and innovations. Her work has garnered attention for its potential applications in medical treatments and health improvement.

Collaborations

Kakuma has collaborated with esteemed colleagues, including Toshitsugu Miyazaki and Kunio Kosaka. These partnerships have contributed to her research and the advancement of her patented methods.

Conclusion

Miyako Kakuma's contributions to the field of hyperlipemia treatment highlight her innovative spirit and dedication to improving health outcomes. Her work exemplifies the impact of research and invention in addressing critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…